Malaria Vaccines

9 registered clinical trials studyying Malaria Vaccines — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Comparison of Two Strategies for Administering the R21-Matrix M Vaccine in a Context of Seasonal Malaria Trans NCT07038837	Epicentre	Phase 4
Recruiting	Infant Malaria Vaccine Schedule Optimization NCT06879327	PATH	Phase 2
Completed	A Study Assessing the Safety, Efficacy, and Impact of GlaxoSmithKline Biologicals' RTS, S/AS01E Malaria Vaccin NCT03855995	GlaxoSmithKline	—
Completed	Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of NCT02699099	GlaxoSmithKline	Phase 3
Completed	Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa NCT02251704	GlaxoSmithKline	Phase 4
Completed	Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine NCT01345240	GlaxoSmithKline	Phase 3
Completed	Epidemiology Study of Malaria Transmission Intensity in Africa NCT01190202	GlaxoSmithKline	N/A
Withdrawn	Phase 1 Study of the Safety and Immunogenicity of a Malaria Transmission-blocking Pfs25-Pfs25 Conjugate Vaccin NCT00977899	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Phase 1
Completed	Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants NCT00289185	GlaxoSmithKline	Phase 2